Evaxion announces completion of ADS ratio change
14 janv. 2025 16h05 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
10 janv. 2025 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, January 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced...
Evaxion announces plan to implement ADS ratio change
30 déc. 2024 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, December 30, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced...
Sify Technologies Ltd. Announces ADS Ratio Change to Be Effective on October 4, 2024
01 oct. 2024 08h49 HE
|
Sify Technologies Limited
CHENNAI, India, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Sify Technologies Ltd. (Nasdaq: Sify) (the “Company”), a leading integrated information communications technology (or ICT) Solutions and Services...
Sify Technologies Ltd. Announces Plan to Implement ADS Ratio Change
18 sept. 2024 10h54 HE
|
Sify Technologies Limited
CHENNAI, India, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sify Technologies Ltd. (Nasdaq: Sify) (the “Company”), a leading integrated information communications technology (or ICT) Solutions and Services...
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
14 mai 2024 02h02 HE
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Burning Rock Announces ADS Ratio Change
26 avr. 2024 01h59 HE
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change
Evaxion Announces Plan to Implement ADS Ratio Change
08 janv. 2024 08h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...